国际妇产科学杂志 ›› 2018, Vol. 45 ›› Issue (1): 101-105.

• 综述 • 上一篇    下一篇

肠道菌群与多囊卵巢综合征关系的研究进展

张宁,李菲,李玲,高海霞   

  1. 250011  济南,山东中医药大学(张宁,李菲,李玲);山东中医药大学附属医院(高海霞)
  • 收稿日期:2017-10-20 修回日期:2018-01-05 出版日期:2018-02-15 发布日期:2018-02-15
  • 通讯作者: 张宁,E-mail:ning_zhang1975@163.com E-mail:ning_zhang1975@163.com
  • 作者简介:2018-01-19
  • 基金资助:
    山东省科技厅重点研发计划项目(2017GSF19107)

Research Progresses of the Association between Gut Microbiome and Polycystic Ovary Syndrome

 ZHANG Ning,LI Fei,LI Ling,GAO Hai-xia   

  1. Shandong University of Traditional Chinese Medicine,Jinan 250011,China(ZHANG Ning,LI Fei,LI Ling);The Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan 250011,China(GAO Hai-xia)
  • Received:2017-10-20 Revised:2018-01-05 Published:2018-02-15 Online:2018-02-15
  • Contact: ZHANG Ning,E-mail:ning_zhang1975@163.com E-mail:ning_zhang1975@163.com

摘要: 多囊卵巢综合征(PCOS)是育龄期女性常见的内分泌紊乱性疾病,主要特征为稀发排卵或不排卵、高雄激素血症、胰岛素抵抗和(或)高胰岛素血症,是导致育龄期女性不孕症的主要原因之一,其发病机制至今仍不完全清楚。肠道菌群作为“成人的第二大脑”,可通过脑-肠轴途径与大脑实现相互影响,从而整合肠道和大脑之间的神经、激素、免疫学信号等多种元素。因此,肠道菌群的失调与肥胖、高脂血症以及胰岛素抵抗等代谢性疾病有极为重要的关系。肠道菌群谱的改变与PCOS的发病及病理过程有关,现综述肠道菌群与PCOS可能的发病机制。

关键词: 多囊卵巢综合征, 代谢疾病, 胰岛素抗药性, 肠杆菌科, 肠道菌群

Abstract: Polycystic ovary syndrome (PCOS) is a common endocrine disorders in women of childbearing age characterized by sporadic ovulation or no ovulation, hyperandrogenism, insulin resistance or hyperinsulinemia. It is one of the leading causes of infertility in women of childbearing age and its pathogenesis is still not fully clear. As "the second brain of the adult", gut microbiome can interact with the brain through the brain gut axis pathway, and integrate the nerve, hormones, immune signals and other elements. Therefore, the imbalance of gut microbiome has an important relationship with metabolic diseases such as obesity, hyperlipidemia and insulin resistance. The change of gut microbiome is closely related to the pathological process of PCOS. This paper reviews the research progresses of possible mechanisms of gut microbiome in the occurrence of PCOS.

Key words: Polycystic ovary syndrome, Metabolic diseases, Insulin resistance, Enterobacteriaceae, Gut microbiome